Related Experiment Videos
[Aftercare or not--that is the question!].
G Schubert-Fritschle1, L Weissbach, D Hölzel
1Tumorregister München des Tumorzentrums München am Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE). gabriele.schubert-fritschle@med.uni-muenchen.de
Der Urologe. Ausg. A
|July 29, 2005
Summary
Urological cancer aftercare in Germany is under scrutiny. Routine diagnostics are not recommended for asymptomatic patients; focus should be on individual needs and recognizing treatment consequences.
Area of Science:
- Oncology
- Urology
- Public Health
Context:
- Approximately 345,000 German patients diagnosed with urological cancer in the last 5 years require healthcare support.
- Aftercare is a crucial component of cancer treatment, but its efficacy is established for limited cancer types.
- For urological cancers, diagnostic aftercare effectiveness is only proven for bladder and testicular cancers.
Purpose:
- To evaluate the effectiveness of current aftercare diagnostic measures for urological cancers.
- To determine the primary objectives of aftercare in urological oncology, focusing on early recurrence detection and curative opportunities.
- To identify reasons for the limited effectiveness of current aftercare protocols.
Summary:
- Evidence for effective diagnostic aftercare in urological cancers is limited, primarily to bladder and testicular cancers, aiming for early recurrence detection.
- The inherent nature of cancer, rather than study design, may explain the limited effectiveness of current diagnostic aftercare.
- The core function of aftercare involves patient communication to assess individual needs and treatment side effects, especially for asymptomatic individuals.
Impact:
- Highlights the need for personalized aftercare strategies in urological cancer management.
- Suggests a shift from routine diagnostics to patient-centered communication in aftercare for asymptomatic patients.
- Informs healthcare providers about the current limitations and appropriate application of diagnostic measures in urological cancer aftercare.